EATRIS, TIA, NCATS and CDRD join forces to share knowledge and insight
EATRIS ERIC, the European Infrastructure for Translational Medicine, has joined forces with three major translational health research organisations to launch a global collaboration in the field of translational research in medicine. Therapeutic Innovation Australia (TIA), The Centre for Drug and Research Development (CDRD) in Canada and the US-based National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) will be...
Genedata Expressionist® for Genomic Profiling helps Takara Bio to manage, process, and analyze large NGS datasets.
The investment in the Genedata platform underlines Takara Bio’s commitment to stay at the forefront of genomic research and to offer highest quality services to its customers. Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Takara Bio Inc., a leading global biotechnology company, has chosen Genedata Expressionist for Genomic Profiling as its key software platform for next-generation sequencing (NGS) data. The platform will be integrated with in-house and third party data analysis tools and...
The S-Lab 2015 Awards for Laboratory Good Practice and Innovation are now open, with a closing date of 12 January 2015.
The categories include design of new and refurbished laboratories, laboratory effectiveness, laboratory environmental improvement, laboratory informatics, and best new or improved laboratory product. The Awards will be presented in conjunction with the ‘Supporting World Class Science’ conference most likely to be held at the University of Bristol on June 16-17 2015. This provides a unique forum for key stakeholders such as science...
Welsh-based scientific instrument manufacturer, Markes International, proved their talents as marketers as well as manufacturers of innovative products for trace organic analysis when the company scooped not one, but two awards at the Chartered Institute of Marketing’s (CIM) Canmol: Wales Marketing Awards.
Markes scooped the award in the Technology and Energy category and were also awarded the “Best of Best” trophy sponsored by Exterion Media Ltd, beating many household brands for their campaign for the new product introduction of Select-eV, variable-energy ionisation technology for mass spectrometry. Commenting on the Markes campaign Canmol judge, Simon Campbell-Davies, said: “One of the key ideas we liked about this campaign was...
Horizon CombinatoRx to perform drug combination screening on lead oncology asset
Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced that its Horizon CombinatoRx division has been contracted by a top ten pharma company to profile a lead oncology asset. Under the terms of the agreement, Horizon CombinatoRx will be paid approximately USD $450,000 (GBP £276,000) for work to be completed within...
Beckman Coulter Life Sciences, through a partnership with New England Biolabs®, Inc. (NEB®), offers automated methods to improve processes and throughput in next generation sequencing (NGS) sample preparation.
Under the agreement, Beckman Coulter will use its extensive experience in automated NGS sample prep to develop, distribute and support automation for NEB’s NEBNext® sample preparation reagent kits. NEB will provide technical expertise on the reagents, chemistry and protocols. Fiona Stewart, Product Marketing Manager for Next Generation Sequencing at NEB said: “We are delighted to have formed this productive partnership with...
Telstar has increased its production of Class III Biological Safety Cabinets by 80% throughout the year 2014 in response to the growing international demand, especially from laboratories and R&D centres located in several African countries.
These type of cabinets have been designed for working with highly infectious microbiological agents (classified as Biosafety Level 4 (BSL-4)) and for conducting hazardous operations and provides maximum protection for the environment and the user. The pathogenic agents which correspond to the group of Biosafety Level 4 are those microorganisms that can cause serious illness in humans and as such constitute a grave danger to personnel, with a high possibility of transfer to other...
Agreement will focus on delivery of the Enigma® Mini Laboratory point of care molecular diagnostic system into the Chinese healthcare market
Enigma Diagnostics Ltd (Enigma), a global leader in molecular diagnostic point-of-care (PoC) infectious disease testing, and Beijing Leadman Biochemistry Co., Ltd. (Beijing Leadman) (SZSE:300289), today announced they have signed a joint venture agreement to support the growing healthcare needs of China’s population. Under the terms of the agreement Beijing Leadman will be Enigma’s exclusive joint venture partner, with the principal goal of delivering the Enigma® Mini Laboratory (“Enigma ML”) PoC molecular diagnostic system to the Chinese market...
Microbiology specialists Lab M will showcase this year’s latest product introductions at Medica 2014 (Düsseldorf, Germany, 12-15 November) with a focus on supporting laboratories in their efforts to maximise process efficiency and optimise workflow.
Here the provision of essential tools, such as convenient or ready-prepared, high quality culture media, is fundamental and Lab M has recently introduced two brand new product lines, µPREP™ and Pinnacle™, to meet these needs. In addition, a new website provides easy access to details of the full range of Lab M microbiology products, with links to the company’s social media channels and newsletter sign up...
Sartorius Stedim Biotech (SSB) has announced that TAP Biosystems, part of SSB Group since 2013, and Merck & Co., Inc. have won two awards at the prestigious 2014 BioProcess International (BPI) Awards.
The awards recognize that the ambr250™ mini bioreactor system, developed as a result of this successful partnership, is a major breakthrough in bioprocessing technology. At the BioProcess International Awards, TAP Biosystems and Merck won the ‘Best Collaboration Award’ beating off stiff competition from other partnerships including Invetech and Janssen. TAP Biosystems and Merck also won the ‘Best Technology Application — Upstream Award’ for the...
BioTek has been awarded U.S. Patent 8,858,718, covering the use of ultrasonic devices to check for clogged manifold tubes and to clean the manifold tubes of a microplate washer automatically.
The two features are known as Verify™ and Ultrasonic Advantage™ and are available in BioTek’s 405 family of microplate washers. Using Verify technology on the 405 washer, the user can run an automated routine to check for blockages, typically caused by protein or salt build-up in the aspirate and dispense tubes of the 405’s manifold. Verify uses ultrasonic pulses to determine that the volume dispensed or aspirated per tube meets...
Non-contact dispensing technologies such as acoustics will evolve into popular platforms for liquid handling, finds Frost & Sullivan
The escalating need for high throughput data is accelerating the shift towards automation in the Western European liquid handling market. Government investments in the development of bioclusters as well as research and development centres for various drug discovery applications are opening up opportunities for liquid handling companies in the region. New analysis from Frost & Sullivan, Western European Liquid Handling Market, finds that the...
BioSilta Ltd, a developer of advanced, reagent-based microbial growth systems, today announced that it has completed the set-up of operational and commercial headquarters in St Ives, Cambridgeshire, UK.
In addition, the Company has strengthened its Board and senior management team with appointments as follows: Mark Bloomfield appointed Chairman. Mark has over 20 years of global management experience and has held executive positions in life science companies such as DAKO, Applied Biosystems, Thermo Electron and Agilent Technologies. He has a proven track record in leading commercially-successful, multi-national teams as well as...
The project is led by a consortium of three institutions based in Lyon, France: Imaxio, the VirPath laboratory at the Université Claude Bernard of Lyon and the International Center for Infectiology Research (CIRI)
The funding will accelerate the pre-clinical development of a candidate influenza vaccine with the aim of starting Phase I trials by 2017. Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has been awarded funding of EUR 600,000 (USD 772,000) by the French National Research Agency (Agence Nationale de la Recherche, ANR) for the OPTIVAC project 'leveraging On t-cell immune resPonse To Improve influenza VACcines'. The aim of the OPTIVAC project is to improve the efficacy of vaccines for seasonal influenza and current pandemics. To achieve this...
The Chancellor of the Exchequer, George Osborne, has announced that a partnership led by the Medical Research Council (MRC) will invest over £230 million in a range of revolutionary technologies aimed at identifying the causes of diseases such as cancer and dementia, and dramatically speeding up diagnosis and treatment.
The state-of-the-art technologies will be used to find out how differences in the cellular and molecular make-up of people affect how they respond to diseases and to treatment. The Clinical Research Infrastructure Initiative will bring together funding from UK Government, devolved administrations, Arthritis Research UK, British Heart Foundation, the Wellcome Trust and Cancer Research UK, to advance clinical research in 23 key projects at centres across the...
Bigneat will now be supporting users of its laboratory automation enclosures and ductless fume hoods with a newly formed team to concentrate on all North American customers.
Bigneat is a world leading manufacturer of hoods and enclosures that provide user and process protection during experimentation and laboratory research procedures. Following a period of growth in demand for its equipment, with a significant increase in the number of users and a wide geographic distribution of installations across North America, Bigneat realized the need to open its first US office to support these customers directly. The Bigneat North American operation brings...
ZEISS congratulates Eric Betzig, Stefan Hell and William Moerner on winning the 2014 Nobel Prize for Chemistry.
All three underscored the value of microscopy in research with their discovery of methods to achieve superresolution. The limit of optical resolution calculated by Ernst Abbe, company founder Carl Zeiss's partner, in the 19th century has been considerably improved through the use of modern technologies. Today, photo-activated localization microscopy (PALM) enables scientists to view processes in living cells and tissues down to the molecular level – in other words, with resolution in...
EnPresso growth systems now available to research scientists through Sigma-Aldrich
BioSilta Ltd, a developer of advanced, reagent-based microbial growth systems, today announced the signing of a non-exclusive worldwide distribution agreement with Sigma-Aldrich® (Nasdaq: SIAL). Research scientists now have the option of ordering BioSilta’s EnPresso® growth systems for microbial cell cultures through global supplier Sigma-Aldrich. BioSilta’s lead product range, EnPresso B growth systems, offer a series of reagent-based...
The P500 offers cost-effective bench top automation for clinical chemistry
The Diatron Group, global provider of hematology and clinical chemistry analyzers, will launch its new economic walk-away clinical chemistry analyzer, the P500, at Medica, Dusseldorf (12-15 November 2014), on booth 3A 07. The new medium throughput system (215 tests/hour on a typical sample mix) is ergonomically designed and user-friendly with a high level of automation that delivers assured result quality. The advanced...
Cytation™ 5 is a uniquely integrated, configurable system that combines automated digital widefield microscopy with conventional multi-mode microplate detection to provide phenotypic cellular information and well-based quantitative data.
Antibiotic Research UK looks to find at least one drug before end of decade
Bacteria are now making antibiotics ineffective. Surgery as we know it today will become impossible – new hips, knees, organ transplantation and many cancer treatments will become high risk. To tackle this impending medical catastrophe a new national charity ‘Antibiotic Research UK– developing new antibiotics’ (acronym ANTRUK ) has been formed by a group of scientific experts from 14 of the country’s top universities and...
LaVison BioTec, developers of advanced microscopy solutions for the life sciences, report on users of their Ultramicroscope Light Sheet Fluorescence Microscope system to aid the research of the Miami Project to Cure Paralysis under the supervision of Professor Vance Lemmon, the Walter G. Ross Distinguished Chair in Developmental Neuroscience & Professor of Neurological Surgery at the University of Miami.
In 2003, Professor Vance Lemmon accepted a position at The Miami Project to Cure Paralysis at the University of Miami. This centre has taken the philosophy that by promoting interactions between basic and clinical scientists, it will be possible to speed the finding of a cure for a devastating clinical problem. This research has focused on answering questions that help define human spinal cord injury and reveal strategies for the repair of damaged spinal tissue...
EATRIS ERIC, the European Infrastructure for Translational Medicine, has joined forces with three major translational health research organisations to launch a global collaboration in the field of translational research in medicine. Therapeutic Innovation Australia (TIA), The Centre for Drug and Research Development (CDRD) in Canada and the US-based National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) will be...
The investment in the Genedata platform underlines Takara Bio’s commitment to stay at the forefront of genomic research and to offer highest quality services to its customers. Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Takara Bio Inc., a leading global biotechnology company, has chosen Genedata Expressionist for Genomic Profiling as its key software platform for next-generation sequencing (NGS) data. The platform will be integrated with in-house and third party data analysis tools and...
The categories include design of new and refurbished laboratories, laboratory effectiveness, laboratory environmental improvement, laboratory informatics, and best new or improved laboratory product. The Awards will be presented in conjunction with the ‘Supporting World Class Science’ conference most likely to be held at the University of Bristol on June 16-17 2015. This provides a unique forum for key stakeholders such as science...
Markes scooped the award in the Technology and Energy category and were also awarded the “Best of Best” trophy sponsored by Exterion Media Ltd, beating many household brands for their campaign for the new product introduction of Select-eV, variable-energy ionisation technology for mass spectrometry. Commenting on the Markes campaign Canmol judge, Simon Campbell-Davies, said: “One of the key ideas we liked about this campaign was...
Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced that its Horizon CombinatoRx division has been contracted by a top ten pharma company to profile a lead oncology asset. Under the terms of the agreement, Horizon CombinatoRx will be paid approximately USD $450,000 (GBP £276,000) for work to be completed within...
Under the agreement, Beckman Coulter will use its extensive experience in automated NGS sample prep to develop, distribute and support automation for NEB’s NEBNext® sample preparation reagent kits. NEB will provide technical expertise on the reagents, chemistry and protocols. Fiona Stewart, Product Marketing Manager for Next Generation Sequencing at NEB said: “We are delighted to have formed this productive partnership with...
These type of cabinets have been designed for working with highly infectious microbiological agents (classified as Biosafety Level 4 (BSL-4)) and for conducting hazardous operations and provides maximum protection for the environment and the user. The pathogenic agents which correspond to the group of Biosafety Level 4 are those microorganisms that can cause serious illness in humans and as such constitute a grave danger to personnel, with a high possibility of transfer to other...
Enigma Diagnostics Ltd (Enigma), a global leader in molecular diagnostic point-of-care (PoC) infectious disease testing, and Beijing Leadman Biochemistry Co., Ltd. (Beijing Leadman) (SZSE:300289), today announced they have signed a joint venture agreement to support the growing healthcare needs of China’s population. Under the terms of the agreement Beijing Leadman will be Enigma’s exclusive joint venture partner, with the principal goal of delivering the Enigma® Mini Laboratory (“Enigma ML”) PoC molecular diagnostic system to the Chinese market...
Here the provision of essential tools, such as convenient or ready-prepared, high quality culture media, is fundamental and Lab M has recently introduced two brand new product lines, µPREP™ and Pinnacle™, to meet these needs. In addition, a new website provides easy access to details of the full range of Lab M microbiology products, with links to the company’s social media channels and newsletter sign up...
The awards recognize that the ambr250™ mini bioreactor system, developed as a result of this successful partnership, is a major breakthrough in bioprocessing technology. At the BioProcess International Awards, TAP Biosystems and Merck won the ‘Best Collaboration Award’ beating off stiff competition from other partnerships including Invetech and Janssen. TAP Biosystems and Merck also won the ‘Best Technology Application — Upstream Award’ for the...
The two features are known as Verify™ and Ultrasonic Advantage™ and are available in BioTek’s 405 family of microplate washers. Using Verify technology on the 405 washer, the user can run an automated routine to check for blockages, typically caused by protein or salt build-up in the aspirate and dispense tubes of the 405’s manifold. Verify uses ultrasonic pulses to determine that the volume dispensed or aspirated per tube meets...
The escalating need for high throughput data is accelerating the shift towards automation in the Western European liquid handling market. Government investments in the development of bioclusters as well as research and development centres for various drug discovery applications are opening up opportunities for liquid handling companies in the region. New analysis from Frost & Sullivan, Western European Liquid Handling Market, finds that the...
In addition, the Company has strengthened its Board and senior management team with appointments as follows: Mark Bloomfield appointed Chairman. Mark has over 20 years of global management experience and has held executive positions in life science companies such as DAKO, Applied Biosystems, Thermo Electron and Agilent Technologies. He has a proven track record in leading commercially-successful, multi-national teams as well as...
The state-of-the-art technologies will be used to find out how differences in the cellular and molecular make-up of people affect how they respond to diseases and to treatment. The Clinical Research Infrastructure Initiative will bring together funding from UK Government, devolved administrations, Arthritis Research UK, British Heart Foundation, the Wellcome Trust and Cancer Research UK, to advance clinical research in 23 key projects at centres across the...
Bigneat is a world leading manufacturer of hoods and enclosures that provide user and process protection during experimentation and laboratory research procedures. Following a period of growth in demand for its equipment, with a significant increase in the number of users and a wide geographic distribution of installations across North America, Bigneat realized the need to open its first US office to support these customers directly. The Bigneat North American operation brings...
All three underscored the value of microscopy in research with their discovery of methods to achieve superresolution. The limit of optical resolution calculated by Ernst Abbe, company founder Carl Zeiss's partner, in the 19th century has been considerably improved through the use of modern technologies. Today, photo-activated localization microscopy (PALM) enables scientists to view processes in living cells and tissues down to the molecular level – in other words, with resolution in...
The Diatron Group, global provider of hematology and clinical chemistry analyzers, will launch its new economic walk-away clinical chemistry analyzer, the P500, at Medica, Dusseldorf (12-15 November 2014), on booth 3A 07. The new medium throughput system (215 tests/hour on a typical sample mix) is ergonomically designed and user-friendly with a high level of automation that delivers assured result quality. The advanced...
Bacteria are now making antibiotics ineffective. Surgery as we know it today will become impossible – new hips, knees, organ transplantation and many cancer treatments will become high risk. To tackle this impending medical catastrophe a new national charity ‘Antibiotic Research UK– developing new antibiotics’ (acronym ANTRUK ) has been formed by a group of scientific experts from 14 of the country’s top universities and...
In 2003, Professor Vance Lemmon accepted a position at The Miami Project to Cure Paralysis at the University of Miami. This centre has taken the philosophy that by promoting interactions between basic and clinical scientists, it will be possible to speed the finding of a cure for a devastating clinical problem. This research has focused on answering questions that help define human spinal cord injury and reveal strategies for the repair of damaged spinal tissue...